(PRWEB) February 20, 2013
Clinical laboratory testing is one of the most important sectors of medical care. Although it is generally involved in over 70% of medical diagnoses, it accounts for less than 5% of overall healthcare expenditures. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma, urine and saliva. This TriMark Publications report describes the specific segments of the clinical laboratory testing business and the strategies used by laboratory companies to develop new business opportunities.
The study presents emerging business practices and analyzes the partnerships and alliances that various key sector players have forged or could forge in the near future. New clinical laboratory business methods are also examined to identify lead positions and potential future growth areas. Moreover, the report profiles leading companies in the clinical laboratory industry, with a primary focus on companies that actively analyze and market laboratory data.
Companies mentioned include: ACM Medical Laboratory, BioTech MedLab, Caris Diagnostics, EndoChoice Pathways, Geneva Laboratories, IBT Laboratories, LabCorp, MEDTOX Scientific, Inc., Parkway Clinical Laboratories, Quest Diagnostics, Inc., RDL Reference Laboratory, Satellite Laboratory Services
For further information please visit http://www.researchandmarkets.com/research/bp7w4z/clinical
Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716